Vitrolife AB (publ) (STO: VITR)

Market Cap	28.41B
Revenue (ttm)	3.56B
Net Income (ttm)	-3.81B
Shares Out	135.39M
EPS (ttm)	-28.10
PE Ratio	n/a
Forward PE	38.28
Dividend	1.00 (0.48%)
Ex-Dividend Date	n/a

Volume	88,085
Open	218.20
Previous Close	219.00
Day's Range	207.60 - 222.60
52-Week Range	156.00 - 268.00
Beta	1.78
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (pu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 1,123
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR